<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32748079</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>599</StartPage><EndPage>623</EndPage><MedlinePgn>599-623</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-020-02203-0</ELocationID><Abstract><AbstractText>Dysregulated RNA metabolism is emerging as a crucially important mechanism underpinning the pathogenesis of frontotemporal dementia (FTD) and the clinically, genetically and pathologically overlapping disorder of amyotrophic lateral sclerosis (ALS). Heterogeneous nuclear ribonucleoproteins (hnRNPs) comprise a family of RNA-binding proteins with diverse, multi-functional roles across all aspects of mRNA processing. The role of these proteins in neurodegeneration is far from understood. Here, we review some of the unifying mechanisms by which hnRNPs have been directly or indirectly linked with FTD/ALS pathogenesis, including their incorporation into pathological inclusions and their best-known roles in pre-mRNA splicing regulation. We also discuss the broader functionalities of hnRNPs including their roles in cryptic exon repression, stress granule assembly and in co-ordinating the DNA damage response, which are all emerging pathogenic themes in both diseases. We then present an integrated model that depicts how a broad-ranging network of pathogenic events can arise from declining levels of functional hnRNPs that are inadequately compensated for by autoregulatory means. Finally, we provide a comprehensive overview of the most functionally relevant cellular roles, in the context of FTD/ALS pathogenesis, for hnRNPs A1-U.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bampton</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8529-8210</Identifier><AffiliationInfo><Affiliation>The Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gittings</LastName><ForeName>Lauren M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Barrow Neurological Institute, 350 W Thomas Road, Phoenix, AZ, 85013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fratta</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lashley</LastName><ForeName>Tammaryn</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology, London, UK. T.Lashley@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, London, UK. T.Lashley@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatt</LastName><ForeName>Ariana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neuroscience, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FRATTA/JAN15/946-795</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/M008606/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S006508/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034441">Heterogeneous-Nuclear Ribonucleoproteins</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034441" MajorTopicYN="N">Heterogeneous-Nuclear Ribonucleoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Autoregulation</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">RNA</Keyword><Keyword MajorTopicYN="N">hnRNP</Keyword></KeywordList><CoiStatement>The authors have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32748079</ArticleId><ArticleId IdType="pmc">PMC7547044</ArticleId><ArticleId IdType="doi">10.1007/s00401-020-02203-0</ArticleId><ArticleId IdType="pii">10.1007/s00401-020-02203-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbadi D, Yang M, Chenette DM, Andrews JJ, Schneider RJ. Muscle development and regeneration controlled by AUF1-mediated stage-specific degradation of fate-determining checkpoint mRNAs. Proc Natl Acad Sci USA. 2019;116:11285&#x2013;11290. doi: 10.1073/pnas.1901165116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1901165116</ArticleId><ArticleId IdType="pmc">PMC6561290</ArticleId><ArticleId IdType="pubmed">31113881</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamson B, Smogorzewska A, Sigoillot FD, King RW, Elledge SJ. A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as a component of the DNA-damage response. Nat Cell Biol. 2012;14:318&#x2013;328. doi: 10.1038/ncb2426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2426</ArticleId><ArticleId IdType="pmc">PMC3290715</ArticleId><ArticleId IdType="pubmed">22344029</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson MK, St&#xe5;hlberg A, Arvidsson Y, Olofsson A, Semb H, Stenman G, et al. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 2008;9:37. doi: 10.1186/1471-2121-9-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2121-9-37</ArticleId><ArticleId IdType="pmc">PMC2478660</ArticleId><ArticleId IdType="pubmed">18620564</ArticleId></ArticleIdList></Reference><Reference><Citation>Appocher C, Mohagheghi F, Cappelli S, Stuani C, Romano M, Feiguin F, et al. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. Nucleic Acids Res. 2017;45:8026&#x2013;8045. doi: 10.1093/nar/gkx477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx477</ArticleId><ArticleId IdType="pmc">PMC5570092</ArticleId><ArticleId IdType="pubmed">28575377</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold ES, Ling S-C, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci USA. 2013;110:E736&#x2013;E745. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Attig J, de Los R, Mozos I, Haberman N, Wang Z, Emmett W, et al. Splicing repression allows the gradual emergence of new Alu-exons in primate evolution. Elife. 2016 doi: 10.7554/eLife.19545.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.19545</ArticleId><ArticleId IdType="pmc">PMC5115870</ArticleId><ArticleId IdType="pubmed">27861119</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, De Conti L, Avenda&#xf1;o-V&#xe1;zquez SE, Dhir A, Romano M, D&#x2019;Ambrogio A, et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011;30:277&#x2013;288. doi: 10.1038/emboj.2010.310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.310</ArticleId><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakheet T, Williams BRG, Khabar KSA. ARED 2.0: an update of AU-rich element mRNA database. Nucleic Acids Res. 2003;31:421&#x2013;423. doi: 10.1093/nar/gkg023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg023</ArticleId><ArticleId IdType="pmc">PMC165470</ArticleId><ArticleId IdType="pubmed">12520039</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkar N, Kovalik T, Lorenzini I, Spangler S, Lacoste A, Sponaugle K, et al. Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:227&#x2013;247. doi: 10.1007/s00401-017-1785-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1785-8</ArticleId><ArticleId IdType="pmc">PMC5773659</ArticleId><ArticleId IdType="pubmed">29134320</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran-Heravi Y, Van Broeckhoven C, van der Zee J. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum. Neurobiol Dis. 2020;134:104639. doi: 10.1016/j.nbd.2019.104639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104639</ArticleId><ArticleId IdType="pubmed">31626953</ArticleId></ArticleIdList></Reference><Reference><Citation>Baralle FE, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017;18:437&#x2013;451. doi: 10.1038/nrm.2017.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.27</ArticleId><ArticleId IdType="pmc">PMC6839889</ArticleId><ArticleId IdType="pubmed">28488700</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreau C, Paillard L, Osborne HB. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 2005;33:7138&#x2013;7150. doi: 10.1093/nar/gki1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki1012</ArticleId><ArticleId IdType="pmc">PMC1325018</ArticleId><ArticleId IdType="pubmed">16391004</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer AL, Christensen ME, Walker BW, LeStourgeon WM. Identification and characterization of the packaging proteins of core 40S hnRNP particles. Cell. 1977;11:127&#x2013;138. doi: 10.1016/0092-8674(77)90323-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(77)90323-3</ArticleId><ArticleId IdType="pubmed">872217</ArticleId></ArticleIdList></Reference><Reference><Citation>Birsa N, Bentham MP, Fratta P. Cytoplasmic functions of TDP-43 and FUS and their role in ALS. Semin Cell Dev Biol. 2020;99:193&#x2013;201. doi: 10.1016/j.semcdb.2019.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.05.023</ArticleId><ArticleId IdType="pubmed">31132467</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Koppers M, Groen EJN, van den Heuvel DMA, Dini Modigliani S, et al. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol. 2016;132:175&#x2013;196. doi: 10.1007/s00401-016-1575-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1575-8</ArticleId><ArticleId IdType="pmc">PMC4947123</ArticleId><ArticleId IdType="pubmed">27164932</ArticleId></ArticleIdList></Reference><Reference><Citation>Bomsztyk K, Denisenko O, Ostrowski J. hnRNP K: one protein multiple processes. BioEssays. 2004;26:629&#x2013;638. doi: 10.1002/bies.20048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.20048</ArticleId><ArticleId IdType="pubmed">15170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick J, Wang J, Andreadis A. Heterogeneous nuclear ribonucleoprotein E2 binds to tau exon 10 and moderately activates its splicing. Gene. 2004;331:107&#x2013;114. doi: 10.1016/j.gene.2004.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2004.02.005</ArticleId><ArticleId IdType="pubmed">15094196</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE. TDP-43: new aspects of autoregulation mechanisms in RNA binding proteins and their connection with human disease. FEBS J. 2011;278:3530&#x2013;3538. doi: 10.1111/j.1742-4658.2011.08257.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2011.08257.x</ArticleId><ArticleId IdType="pubmed">21777388</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabretta S, Richard S. Emerging roles of disordered sequences in RNA-binding proteins. Trends Biochem Sci. 2015;40:662&#x2013;672. doi: 10.1016/j.tibs.2015.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.08.012</ArticleId><ArticleId IdType="pubmed">26481498</ArticleId></ArticleIdList></Reference><Reference><Citation>Calarco JA. &#x201c;Cryptic&#x201d; exons reveal some of their secrets. Elife. 2013;2:e00476. doi: 10.7554/eLife.00476.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.00476</ArticleId><ArticleId IdType="pmc">PMC3552425</ArticleId><ArticleId IdType="pubmed">23358458</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvio C, Neubauer G, Mann M, Lamond AI. Identification of hnRNP P2 as TLS/FUS using electrospray mass spectrometry. RNA. 1995;1:724&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369314</ArticleId><ArticleId IdType="pubmed">7585257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappelli S, Romano M, Buratti E. Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human RNA binding proteins implicated in mRNA processing mechanisms. Front Mol Biosci. 2018;5:79. doi: 10.3389/fmolb.2018.00079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2018.00079</ArticleId><ArticleId IdType="pmc">PMC6125337</ArticleId><ArticleId IdType="pubmed">30214903</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputi M, Zahler AM. Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H&#x2019;/F/2H9 family. J Biol Chem. 2001;276:43850&#x2013;43859. doi: 10.1074/jbc.M102861200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M102861200</ArticleId><ArticleId IdType="pubmed">11571276</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter B, McKay M, Dundas SR, Lawrie LC, Telfer C, Murray GI. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer. 2006;95:921&#x2013;927. doi: 10.1038/sj.bjc.6603349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6603349</ArticleId><ArticleId IdType="pmc">PMC2360539</ArticleId><ArticleId IdType="pubmed">16953238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabot B, Blanchette M, Lapierre I, La Branche H. An intron element modulating 5&#x2032; splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol Cell Biol. 1997;17:1776&#x2013;1786. doi: 10.1128/mcb.17.4.1776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.17.4.1776</ArticleId><ArticleId IdType="pmc">PMC232024</ArticleId><ArticleId IdType="pubmed">9121425</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhury A, Chander P, Howe PH. Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1&#x2019;s multifunctional regulatory roles. RNA. 2010;16:1449&#x2013;1462. doi: 10.1261/rna.2254110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.2254110</ArticleId><ArticleId IdType="pmc">PMC2905745</ArticleId><ArticleId IdType="pubmed">20584894</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CY, Xu N, Shyu AB. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol Cell Biol. 1995;15:5777&#x2013;5788. doi: 10.1128/mcb.15.10.5777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.15.10.5777</ArticleId><ArticleId IdType="pmc">PMC230830</ArticleId><ArticleId IdType="pubmed">7565731</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Gu P, Xie R, Han J, Liu H, Wang B, et al. Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer. J Cell Mol Med. 2017;21:1266&#x2013;1279. doi: 10.1111/jcmm.12999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12999</ArticleId><ArticleId IdType="pmc">PMC5487918</ArticleId><ArticleId IdType="pubmed">27862976</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenette DM, Cadwallader AB, Antwine TL, Larkin LC, Wang J, Olwin BB, et al. Targeted mRNA decay by RNA binding protein AUF1 regulates adult muscle stem cell fate, promoting skeletal muscle integrity. Cell Rep. 2016;16:1379&#x2013;1390. doi: 10.1016/j.celrep.2016.06.095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.06.095</ArticleId><ArticleId IdType="pmc">PMC5323095</ArticleId><ArticleId IdType="pubmed">27452471</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho S, Moon H, Loh TJ, Oh HK, Cho S, Choy HE, et al. hnRNP M facilitates exon 7 inclusion of SMN2 pre-mRNA in spinal muscular atrophy by targeting an enhancer on exon 7. Biochim Biophys Acta. 2014;1839:306&#x2013;315. doi: 10.1016/j.bbagrm.2014.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2014.02.006</ArticleId><ArticleId IdType="pubmed">24533984</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi YD, Dreyfuss G. Monoclonal antibody characterization of the C proteins of heterogeneous nuclear ribonucleoprotein complexes in vertebrate cells. J Cell Biol. 1984;99:1997&#x2013;2204. doi: 10.1083/jcb.99.6.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.99.6.1997</ArticleId><ArticleId IdType="pmc">PMC2113551</ArticleId><ArticleId IdType="pubmed">6209285</ArticleId></ArticleIdList></Reference><Reference><Citation>Cienikov&#xe1; Z, Jayne S, Damberger FF, Allain FH-T, Maris C. Evidence for cooperative tandem binding of hnRNP C RRMs in mRNA processing. RNA. 2015;21:1931&#x2013;1942. doi: 10.1261/rna.052373.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.052373.115</ArticleId><ArticleId IdType="pmc">PMC4604433</ArticleId><ArticleId IdType="pubmed">26370582</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon EG, Fagegaltier D, Agius P, Davis-Porada J, Gregory J, Hubbard I, et al. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism. Elife. 2018 doi: 10.7554/eLife.37754.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37754</ArticleId><ArticleId IdType="pmc">PMC6103746</ArticleId><ArticleId IdType="pubmed">30003873</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon EG, Lu L, Sharma A, Yamazaki T, Tang T, Shneider NA, et al. The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. Elife. 2016 doi: 10.7554/eLife.17820.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.17820</ArticleId><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Walsh MJ, Higginbottom A, Robin Highley J, Dickman MJ, Edbauer D, et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain. 2014;137:2040&#x2013;2051. doi: 10.1093/brain/awu120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu120</ArticleId><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragnaz L, Klima R, De Conti L, Romano G, Feiguin F, Buratti E, et al. An age-related reduction of brain TBPH/TDP-43 levels precedes the onset of locomotion defects in a Drosophila ALS model. Neuroscience. 2015;311:415&#x2013;421. doi: 10.1016/j.neuroscience.2015.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.10.037</ArticleId><ArticleId IdType="pubmed">26518462</ArticleId></ArticleIdList></Reference><Reference><Citation>Crozat A, Aman P, Mandahl N, Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature. 1993;363:640&#x2013;644. doi: 10.1038/363640a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/363640a0</ArticleId><ArticleId IdType="pubmed">8510758</ArticleId></ArticleIdList></Reference><Reference><Citation>Czubaty A, Girstun A, Kowalska-Loth B, Trzci&#x144;ska AM, Purta E, Winczura A, et al. Proteomic analysis of complexes formed by human topoisomerase I. Biochim Biophys Acta. 2005;1749:133&#x2013;141. doi: 10.1016/j.bbapap.2005.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2005.03.007</ArticleId><ArticleId IdType="pubmed">15848144</ArticleId></ArticleIdList></Reference><Reference><Citation>Datar KV, Dreyfuss G, Swanson MS. The human hnRNP M proteins: identification of a methionine/arginine-rich repeat motif in ribonucleoproteins. Nucleic Acids Res. 1993;21:439&#x2013;446. doi: 10.1093/nar/21.3.439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/21.3.439</ArticleId><ArticleId IdType="pmc">PMC309137</ArticleId><ArticleId IdType="pubmed">8441656</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson YS, Flood L, Robinson AC, Nihei Y, Mori K, Rollinson S, et al. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 gene. Acta Neuropathol Commun. 2017;5:31. doi: 10.1186/s40478-017-0437-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0437-5</ArticleId><ArticleId IdType="pmc">PMC5399321</ArticleId><ArticleId IdType="pubmed">28431575</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson YS, Robinson AC, Flood L, Rollinson S, Benson BC, et al. Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in semantic dementia but not with other TDP-43 pathological subtypes of frontotemporal lobar degeneration. Acta Neuropathol Commun. 2017;5:54. doi: 10.1186/s40478-017-0454-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0454-4</ArticleId><ArticleId IdType="pmc">PMC5493127</ArticleId><ArticleId IdType="pubmed">28666471</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejgaard K, Leffers H. Characterisation of the nucleic-acid-binding activity of KH domains. Different properties of different domains. Eur J Biochem. 1996;241:425&#x2013;431. doi: 10.1111/j.1432-1033.1996.00425.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1996.00425.x</ArticleId><ArticleId IdType="pubmed">8917439</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshaies J-E, Shkreta L, Moszczynski AJ, Sidib&#xe9; H, Semmler S, Fouillen A, et al. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain. 2018;141:1320&#x2013;1333. doi: 10.1093/brain/awy062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy062</ArticleId><ArticleId IdType="pmc">PMC5917749</ArticleId><ArticleId IdType="pubmed">29562314</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Kouri N, Murray ME, Josephs KA. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau) J Mol Neurosci. 2011;45:384&#x2013;389. doi: 10.1007/s12031-011-9589-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-011-9589-0</ArticleId><ArticleId IdType="pmc">PMC3208128</ArticleId><ArticleId IdType="pubmed">21720721</ArticleId></ArticleIdList></Reference><Reference><Citation>Donahue CP, Muratore C, Wu JY, Kosik KS, Wolfe MS. Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing. J Biol Chem. 2006;281:23302&#x2013;23306. doi: 10.1074/jbc.C600143200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C600143200</ArticleId><ArticleId IdType="pmc">PMC2072867</ArticleId><ArticleId IdType="pubmed">16782711</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreyfuss G, Kim VN, Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol. 2002;3:195&#x2013;205. doi: 10.1038/nrm760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm760</ArticleId><ArticleId IdType="pubmed">11994740</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreyfuss G, Matunis MJ, Pi&#xf1;ol-Roma S, Burd CG. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem. 1993;62:289&#x2013;321. doi: 10.1146/annurev.bi.62.070193.001445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bi.62.070193.001445</ArticleId><ArticleId IdType="pubmed">8352591</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvinge H. Regulation of alternative mRNA splicing: old players and new perspectives. FEBS Lett. 2018;592:2987&#x2013;3006. doi: 10.1002/1873-3468.13119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13119</ArticleId><ArticleId IdType="pubmed">29856907</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkelenz S, Mueller WF, Evans MS, Busch A, Sch&#xf6;neweis K, Hertel KJ, et al. Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms. RNA. 2013;19:96&#x2013;102. doi: 10.1261/rna.037044.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.037044.112</ArticleId><ArticleId IdType="pmc">PMC3527730</ArticleId><ArticleId IdType="pubmed">23175589</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Kapogiannis D, Huey ED, Momeni P. FTD and ALS: a tale of two diseases. Curr Alzheimer Res. 2011;8:273&#x2013;294. doi: 10.2174/156720511795563700.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720511795563700</ArticleId><ArticleId IdType="pmc">PMC3801195</ArticleId><ArticleId IdType="pubmed">21222600</ArticleId></ArticleIdList></Reference><Reference><Citation>Fifita JA, Zhang KY, Galper J, Williams KL, McCann EP, Hogan AL, et al. Genetic and pathological assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in familial and sporadic amyotrophic lateral sclerosis. Neurodegener Dis. 2017;17:304&#x2013;312. doi: 10.1159/000481258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000481258</ArticleId><ArticleId IdType="pubmed">29131108</ArticleId></ArticleIdList></Reference><Reference><Citation>Folci A, Mapelli L, Sassone J, Prestori F, D&#x2019;Angelo E, Bassani S, et al. Loss of hnRNP K impairs synaptic plasticity in hippocampal neurons. J Neurosci. 2014;34:9088&#x2013;9095. doi: 10.1523/JNEUROSCI.0303-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0303-14.2014</ArticleId><ArticleId IdType="pmc">PMC6608249</ArticleId><ArticleId IdType="pubmed">24990929</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, Sivakumar P, Humphrey J, Lo K, Ricketts T, Oliveira H, et al. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J. 2018 doi: 10.15252/embj.201798684.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798684</ArticleId><ArticleId IdType="pmc">PMC5983119</ArticleId><ArticleId IdType="pubmed">29764981</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res. 2010;9:1104&#x2013;1120. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimura K, Kano F, Murata M. Identification of PCBP2, a facilitator of IRES-mediated translation, as a novel constituent of stress granules and processing bodies. RNA. 2008;14:425&#x2013;431. doi: 10.1261/rna.780708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.780708</ArticleId><ArticleId IdType="pmc">PMC2248264</ArticleId><ArticleId IdType="pubmed">18174314</ArticleId></ArticleIdList></Reference><Reference><Citation>Gami-Patel P, Bandopadhyay R, Brelstaff J, Revesz T, Lashley T. The presence of heterogeneous nuclear ribonucleoproteins in frontotemporal lobar degeneration with FUS-positive inclusions. Neurobiol Aging. 2016;46:192&#x2013;203. doi: 10.1016/j.neurobiolaging.2016.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.07.004</ArticleId><ArticleId IdType="pubmed">27500866</ArticleId></ArticleIdList></Reference><Reference><Citation>Geuens T, Bouhy D, Timmerman V. The hnRNP family: insights into their role in health and disease. Hum Genet. 2016;135:851&#x2013;867. doi: 10.1007/s00439-016-1683-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-016-1683-5</ArticleId><ArticleId IdType="pmc">PMC4947485</ArticleId><ArticleId IdType="pubmed">27215579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghetti A, Pi&#xf1;ol-Roma S, Michael WM, Morandi C, Dreyfuss G. hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs. Nucleic Acids Res. 1992;20:3671&#x2013;3678. doi: 10.1093/nar/20.14.3671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/20.14.3671</ArticleId><ArticleId IdType="pmc">PMC334017</ArticleId><ArticleId IdType="pubmed">1641332</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilpin KM, Chang L, Monteiro MJ. ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1. Hum Mol Genet. 2015;24:2565&#x2013;2577. doi: 10.1093/hmg/ddv020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv020</ArticleId><ArticleId IdType="pubmed">25616961</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, Fryer JD. A matter of balance. Elife. 2018 doi: 10.7554/eLife.40034.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.40034</ArticleId><ArticleId IdType="pmc">PMC6103765</ArticleId><ArticleId IdType="pubmed">30129439</ArticleId></ArticleIdList></Reference><Reference><Citation>Gittings LM, Foti SC, Benson BC, Gami-Patel P, Isaacs AM, Lashley T. Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS. Acta Neuropathol Commun. 2019;7:18. doi: 10.1186/s40478-019-0673-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0673-y</ArticleId><ArticleId IdType="pmc">PMC6371513</ArticleId><ArticleId IdType="pubmed">30755280</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammatikakis I, Zhang P, Panda AC, Kim J, Maudsley S, Abdelmohsen K, et al. Alternative splicing of neuronal differentiation factor TRF2 regulated by HNRNPH1/H2. Cell Rep. 2016;15:926&#x2013;934. doi: 10.1016/j.celrep.2016.03.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.03.080</ArticleId><ArticleId IdType="pmc">PMC4856555</ArticleId><ArticleId IdType="pubmed">27117401</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover A, Houlden H, Baker M, Adamson J, Lewis J, Prihar G, et al. 5&#x2032; splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem. 1999;274:15134&#x2013;15143. doi: 10.1074/jbc.274.21.15134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.21.15134</ArticleId><ArticleId IdType="pubmed">10329720</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Periz G, Simko EAJ, Shaw PG, Kim M-S, et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195&#x2013;200. doi: 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahm B, Cho OH, Kim JE, Kim YK, Kim JH, Oh YL, et al. Polypyrimidine tract-binding protein interacts with HnRNP L. FEBS Lett. 1998;425:401&#x2013;406. doi: 10.1016/s0014-5793(98)00269-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-5793(98)00269-5</ArticleId><ArticleId IdType="pubmed">9563502</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley B, Paunesku T, Proti&#x107; M, Woloschak GE. Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair. Int J Radiat Biol. 2009;85:643&#x2013;655. doi: 10.1080/09553000903009548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09553000903009548</ArticleId><ArticleId IdType="pmc">PMC2785495</ArticleId><ArticleId IdType="pubmed">19579069</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassfeld W, Chan EK, Mathison DA, Portman D, Dreyfuss G, Steiner G, et al. Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: immunological relationship with hnRNP P. Nucleic Acids Res. 1998;26:439&#x2013;445. doi: 10.1093/nar/26.2.439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/26.2.439</ArticleId><ArticleId IdType="pmc">PMC147279</ArticleId><ArticleId IdType="pubmed">9421497</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegde ML, Banerjee S, Hegde PM, Bellot LJ, Hazra TK, Boldogh I, et al. Enhancement of NEIL1 protein-initiated oxidized DNA base excision repair by heterogeneous nuclear ribonucleoprotein U (hnRNP-U) via direct interaction. J Biol Chem. 2012;287:34202&#x2013;34211. doi: 10.1074/jbc.M112.384032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.384032</ArticleId><ArticleId IdType="pmc">PMC3464528</ArticleId><ArticleId IdType="pubmed">22902625</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinrich B, Zhang Z, Raitskin O, Hiller M, Benderska N, Hartmann AM, et al. Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A/C)-rich regions in pre-mRNA. J Biol Chem. 2009;284:14303&#x2013;14315. doi: 10.1074/jbc.M901026200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M901026200</ArticleId><ArticleId IdType="pmc">PMC2682879</ArticleId><ArticleId IdType="pubmed">19282290</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobor F, Dallmann A, Ball NJ, Cicchini C, Battistelli C, Ogrodowicz RW, et al. A cryptic RNA-binding domain mediates Syncrip recognition and exosomal partitioning of miRNA targets. Nat Commun. 2018;9:831. doi: 10.1038/s41467-018-03182-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03182-3</ArticleId><ArticleId IdType="pmc">PMC5827114</ArticleId><ArticleId IdType="pubmed">29483512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann Y, Wirth B. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1. Hum Mol Genet. 2002;11:2037&#x2013;2049. doi: 10.1093/hmg/11.17.2037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.17.2037</ArticleId><ArticleId IdType="pubmed">12165565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, Dormann D. Friend or foe-Post-translational modifications as regulators of phase separation and RNP granule dynamics. J Biol Chem. 2019;294:7137&#x2013;7150. doi: 10.1074/jbc.TM118.001189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.001189</ArticleId><ArticleId IdType="pmc">PMC6509508</ArticleId><ArticleId IdType="pubmed">30587571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, Hutten S, Bourgeois B, Spreitzer E, Niedner-Boblenz A, Schifferer M, et al. Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell. 2018;173:706&#x2013;719.e13. doi: 10.1016/j.cell.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.004</ArticleId><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda H, Hamasaki H, Wakamiya T, Koyama S, Suzuki SO, Fujii N, et al. Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions. Neuropathology. 2015;35:37&#x2013;43. doi: 10.1111/neup.12153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12153</ArticleId><ArticleId IdType="pubmed">25338872</ArticleId></ArticleIdList></Reference><Reference><Citation>Honor&#xe9; B, Rasmussen HH, Vorum H, Dejgaard K, Liu X, Gromov P, et al. Heterogeneous nuclear ribonucleoproteins H, H&#x2032;, and F are members of a ubiquitously expressed subfamily of related but distinct proteins encoded by genes mapping to different chromosomes. J Biol Chem. 1995;270:28780&#x2013;28789. doi: 10.1074/jbc.270.48.28780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.48.28780</ArticleId><ArticleId IdType="pubmed">7499401</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovhannisyan RH, Carstens RP. Heterogeneous ribonucleoprotein m is a splicing regulatory protein that can enhance or silence splicing of alternatively spliced exons. J Biol Chem. 2007;282:36265&#x2013;36274. doi: 10.1074/jbc.M704188200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M704188200</ArticleId><ArticleId IdType="pubmed">17959601</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Chen X, Wu K, Xu P. Cloning and expression of a novel isoform of heterogeneous nuclear ribonucleoprotein-R. NeuroReport. 2005;16:727&#x2013;730. doi: 10.1097/00001756-200505120-00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200505120-00014</ArticleId><ArticleId IdType="pubmed">15858414</ArticleId></ArticleIdList></Reference><Reference><Citation>Huelga SC, Vu AQ, Arnold JD, Liang TY, Liu PP, Yan BY, et al. Integrative genome-wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins. Cell Rep. 2012;1:167&#x2013;178. doi: 10.1016/j.celrep.2012.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.02.001</ArticleId><ArticleId IdType="pmc">PMC3345519</ArticleId><ArticleId IdType="pubmed">22574288</ArticleId></ArticleIdList></Reference><Reference><Citation>Hug N, Longman D, C&#xe1;ceres JF. Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res. 2016;44:1483&#x2013;1495. doi: 10.1093/nar/gkw010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw010</ArticleId><ArticleId IdType="pmc">PMC4770240</ArticleId><ArticleId IdType="pubmed">26773057</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J, Birsa N, Milioto C, McLaughlin M, Ule AM, Robaldo D, et al. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucleic Acids Res. 2020 doi: 10.1093/nar/gkaa410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa410</ArticleId><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="pubmed">32479602</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J, Emmett W, Fratta P, Isaacs AM, Plagnol V. Quantitative analysis of cryptic splicing associated with TDP-43 depletion. BMC Med Genomics. 2017;10:38. doi: 10.1186/s12920-017-0274-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-017-0274-1</ArticleId><ArticleId IdType="pmc">PMC5446763</ArticleId><ArticleId IdType="pubmed">28549443</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung L-H, Heiner M, Hui J, Schreiner S, Benes V, Bindereif A. Diverse roles of hnRNP L in mammalian mRNA processing: a combined microarray and RNAi analysis. RNA. 2008;14:284&#x2013;296. doi: 10.1261/rna.725208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.725208</ArticleId><ArticleId IdType="pmc">PMC2212255</ArticleId><ArticleId IdType="pubmed">18073345</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071&#x2013;1078. doi: 10.1038/nature08467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08467</ArticleId><ArticleId IdType="pmc">PMC2906700</ArticleId><ArticleId IdType="pubmed">19847258</ArticleId></ArticleIdList></Reference><Reference><Citation>Jean-Philippe J, Paz S, Caputi M. hnRNP A1: the Swiss army knife of gene expression. Int J Mol Sci. 2013;14:18999&#x2013;19024. doi: 10.3390/ijms140918999.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms140918999</ArticleId><ArticleId IdType="pmc">PMC3794818</ArticleId><ArticleId IdType="pubmed">24065100</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurica MS, Licklider LJ, Gygi SR, Grigorieff N, Moore MJ. Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA. 2002;8:426&#x2013;439. doi: 10.1017/s1355838202021088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1355838202021088</ArticleId><ArticleId IdType="pmc">PMC1370266</ArticleId><ArticleId IdType="pubmed">11991638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashima T, Manley JL. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet. 2003;34:460&#x2013;463. doi: 10.1038/ng1207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1207</ArticleId><ArticleId IdType="pubmed">12833158</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattuah W, Rogelj B, King A, Shaw CE, Hortob&#xe1;gyi T, Troakes C. Heterogeneous nuclear ribonucleoprotein E2 (hnRNP E2) is a component of TDP-43 aggregates specifically in the A and C pathological subtypes of frontotemporal lobar degeneration. Front Neurosci. 2019;13:551. doi: 10.3389/fnins.2019.00551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00551</ArticleId><ArticleId IdType="pmc">PMC6558155</ArticleId><ArticleId IdType="pubmed">31213972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami I, Arai T, Hasegawa M. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathol. 2019;138:751&#x2013;770. doi: 10.1007/s00401-019-02077-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02077-x</ArticleId><ArticleId IdType="pmc">PMC6800885</ArticleId><ArticleId IdType="pubmed">31555895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemmerer K, Fischer S, Weigand JE. Auto- and cross-regulation of the hnRNPs D and DL. RNA. 2018;24:324&#x2013;331. doi: 10.1261/rna.063420.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.063420.117</ArticleId><ArticleId IdType="pmc">PMC5824352</ArticleId><ArticleId IdType="pubmed">29263134</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiledjian M, Dreyfuss G. Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box. EMBO J. 1992;11:2655&#x2013;2664. doi: 10.1002/j.1460-2075.1992.tb05331.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1992.tb05331.x</ArticleId><ArticleId IdType="pmc">PMC556741</ArticleId><ArticleId IdType="pubmed">1628625</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BW, Jeong YE, Wong M, Martin LJ. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations. Acta Neuropathol Commun. 2020;8:7. doi: 10.1186/s40478-019-0874-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0874-4</ArticleId><ArticleId IdType="pmc">PMC6995159</ArticleId><ArticleId IdType="pubmed">32005289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D-Y, Kwak E, Kim S-H, Lee K-H, Woo K-C, Kim K-T. hnRNP Q mediates a phase-dependent translation-coupled mRNA decay of mouse Period3. Nucleic Acids Res. 2011;39:8901&#x2013;8914. doi: 10.1093/nar/gkr605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr605</ArticleId><ArticleId IdType="pmc">PMC3203584</ArticleId><ArticleId IdType="pubmed">21785138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D-Y, Woo K-C, Lee K-H, Kim T-D, Kim K-T. hnRNP Q and PTB modulate the circadian oscillation of mouse Rev-erb alpha via IRES-mediated translation. Nucleic Acids Res. 2010;38:7068&#x2013;7078. doi: 10.1093/nar/gkq569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq569</ArticleId><ArticleId IdType="pmc">PMC2978350</ArticleId><ArticleId IdType="pubmed">20576698</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kim NC, Wang Y-D, Scarborough EA, Moore J, Diaz Z, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H-J, Raphael AR, LaDow ES, McGurk L, Weber RA, Trojanowski JQ, et al. Therapeutic modulation of eIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet. 2014;46:152&#x2013;160. doi: 10.1038/ng.2853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2853</ArticleId><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishor A, Ge Z, Hogg JR. hnRNP L-dependent protection of normal mRNAs from NMD subverts quality control in B cell lymphoma. EMBO J. 2019 doi: 10.15252/embj.201899128.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201899128</ArticleId><ArticleId IdType="pmc">PMC6356069</ArticleId><ArticleId IdType="pubmed">30530525</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci. 2019;22:167&#x2013;179. doi: 10.1038/s41593-018-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosturko LD, Maggipinto MJ, Korza G, Lee JW, Carson JH, Barbarese E. Heterogeneous nuclear ribonucleoprotein (hnRNP) E1 binds to hnRNP A2 and inhibits translation of A2 response element mRNAs. Mol Biol Cell. 2006;17:3521&#x2013;3533. doi: 10.1091/mbc.e05-10-0946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e05-10-0946</ArticleId><ArticleId IdType="pmc">PMC1525244</ArticleId><ArticleId IdType="pubmed">16775011</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama A, Sugai A, Kato T, Ishihara T, Shiga A, Toyoshima Y, et al. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43. Nucleic Acids Res. 2016;44:5820&#x2013;5836. doi: 10.1093/nar/gkw499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw499</ArticleId><ArticleId IdType="pmc">PMC4937342</ArticleId><ArticleId IdType="pubmed">27257061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacovich V, Espindola SL, Alloatti M, Pozo Devoto V, Cromberg LE, &#x10c;arn&#xe1; ME, et al. Tau isoforms imbalance impairs the axonal transport of the amyloid precursor protein in human neurons. J Neurosci. 2017;37:58&#x2013;69. doi: 10.1523/JNEUROSCI.2305-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2305-16.2016</ArticleId><ArticleId IdType="pmc">PMC6705673</ArticleId><ArticleId IdType="pubmed">28053030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet. 2010;19:R46&#x2013;64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamichhane R, Daubner GM, Thomas-Crusells J, Auweter SD, Manatschal C, Austin KS, et al. RNA looping by PTB: evidence using FRET and NMR spectroscopy for a role in splicing repression. Proc Natl Acad Sci USA. 2010;107:4105&#x2013;4110. doi: 10.1073/pnas.0907072107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0907072107</ArticleId><ArticleId IdType="pmc">PMC2840148</ArticleId><ArticleId IdType="pubmed">20160105</ArticleId></ArticleIdList></Reference><Reference><Citation>Laroia G, Cuesta R, Brewer G, Schneider RJ. Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science. 1999;284:499&#x2013;502. doi: 10.1126/science.284.5413.499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.284.5413.499</ArticleId><ArticleId IdType="pubmed">10205060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashley T, Rohrer JD, Bandopadhyay R, Fry C, Ahmed Z, Isaacs AM, et al. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain. 2011;134:2548&#x2013;2564. doi: 10.1093/brain/awr160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr160</ArticleId><ArticleId IdType="pmc">PMC3170529</ArticleId><ArticleId IdType="pubmed">21752791</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashley T, Rohrer JD, Mead S, Revesz T. Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol Appl Neurobiol. 2015;41:858&#x2013;881. doi: 10.1111/nan.12250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12250</ArticleId><ArticleId IdType="pubmed">26041104</ArticleId></ArticleIdList></Reference><Reference><Citation>Laursen LS, Chan CW, Ffrench-Constant C. Translation of myelin basic protein mRNA in oligodendrocytes is regulated by integrin activation and hnRNP-K. J Cell Biol. 2011;192:797&#x2013;811. doi: 10.1083/jcb.201007014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201007014</ArticleId><ArticleId IdType="pmc">PMC3051817</ArticleId><ArticleId IdType="pubmed">21357748</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Lee VM-Y, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci. 2012;13:38&#x2013;50. doi: 10.1038/nrn3121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3121</ArticleId><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK, et al. Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol. 2017;134:65&#x2013;78. doi: 10.1007/s00401-017-1679-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1679-9</ArticleId><ArticleId IdType="pmc">PMC5521959</ArticleId><ArticleId IdType="pubmed">28130640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H-R, Kim T-D, Kim H-J, Jung Y, Lee D, Lee K-H, et al. Heterogeneous ribonucleoprotein R regulates arylalkylamine N-acetyltransferase synthesis via internal ribosomal entry site-mediated translation in a circadian manner. J Pineal Res. 2015;59:518&#x2013;529. doi: 10.1111/jpi.12284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12284</ArticleId><ArticleId IdType="pubmed">26444903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y-B, Chen H-J, Peres JN, Gomez-Deza J, Attig J, Stalekar M, et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 2013;5:1178&#x2013;1186. doi: 10.1016/j.celrep.2013.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Chhabra R, Merran JD, Schaughency PM, Wheelan SJ, Corden JL, et al. PTBP1 and PTBP2 repress nonconserved cryptic exons. Cell Rep. 2016;17:104&#x2013;113. doi: 10.1016/j.celrep.2016.08.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.08.071</ArticleId><ArticleId IdType="pmc">PMC5082185</ArticleId><ArticleId IdType="pubmed">27681424</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349:650&#x2013;655. doi: 10.1126/science.aab0983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S-C, Albuquerque CP, Han JS, Lagier-Tourenne C, Tokunaga S, Zhou H, et al. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci USA. 2010;107:13318&#x2013;13323. doi: 10.1073/pnas.1008227107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008227107</ArticleId><ArticleId IdType="pmc">PMC2922163</ArticleId><ArticleId IdType="pubmed">20624952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S-C, Dastidar SG, Tokunaga S, Ho WY, Lim K, Ilieva H, et al. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis. Elife. 2019 doi: 10.7554/eLife.40811.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.40811</ArticleId><ArticleId IdType="pmc">PMC6389288</ArticleId><ArticleId IdType="pubmed">30747709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S-C, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Kim D, Choi N, Oh J, Ha J, Zhou J, et al. hnRNP A1 regulates alternative splicing of tau exon 10 by targeting 3&#x2032; splice sites. Cells. 2020 doi: 10.3390/cells9040936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040936</ArticleId><ArticleId IdType="pmc">PMC7226981</ArticleId><ArticleId IdType="pubmed">32290247</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Szaro BG. hnRNP K post-transcriptionally co-regulates multiple cytoskeletal genes needed for axonogenesis. Development. 2011;138:3079&#x2013;3090. doi: 10.1242/dev.066993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.066993</ArticleId><ArticleId IdType="pubmed">21693523</ArticleId></ArticleIdList></Reference><Reference><Citation>Loflin P, Chen CY, Shyu AB. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev. 1999;13:1884&#x2013;1897. doi: 10.1101/gad.13.14.1884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.13.14.1884</ArticleId><ArticleId IdType="pmc">PMC316883</ArticleId><ArticleId IdType="pubmed">10421639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF, Karydas A, Tran H, Yang D, et al. Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald CC. Tissue-specific mechanisms of alternative polyadenylation: testis, brain, and beyond (2018 update) Wiley Interdiscip Rev RNA. 2019;10:e1526. doi: 10.1002/wrna.1526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1526</ArticleId><ArticleId IdType="pmc">PMC6617714</ArticleId><ArticleId IdType="pubmed">30816016</ArticleId></ArticleIdList></Reference><Reference><Citation>Makeyev AV, Chkheidze AN, Liebhaber SA. A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog. J Biol Chem. 1999;274:24849&#x2013;24857. doi: 10.1074/jbc.274.35.24849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.35.24849</ArticleId><ArticleId IdType="pubmed">10455157</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandler MD, Ku L, Feng Y. A cytoplasmic quaking I isoform regulates the hnRNP F/H-dependent alternative splicing pathway in myelinating glia. Nucleic Acids Res. 2014;42:7319&#x2013;7329. doi: 10.1093/nar/gku353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku353</ArticleId><ArticleId IdType="pmc">PMC4066780</ArticleId><ArticleId IdType="pubmed">24792162</ArticleId></ArticleIdList></Reference><Reference><Citation>Marko M, Leichter M, Patrinou-Georgoula M, Guialis A. hnRNP M interacts with PSF and p54(nrb) and co-localizes within defined nuclear structures. Exp Cell Res. 2010;316:390&#x2013;400. doi: 10.1016/j.yexcr.2009.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2009.10.021</ArticleId><ArticleId IdType="pubmed">19874820</ArticleId></ArticleIdList></Reference><Reference><Citation>Marko M, Leichter M, Patrinou-Georgoula M, Guialis A. Selective interactions of hnRNP M isoforms with the TET proteins TAF15 and TLS/FUS. Mol Biol Rep. 2014;41:2687&#x2013;2695. doi: 10.1007/s11033-014-3128-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-014-3128-3</ArticleId><ArticleId IdType="pubmed">24474660</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez FJ, Pratt GA, Van Nostrand EL, Batra R, Huelga SC, Kapeli K, et al. Protein-RNA networks regulated by normal and ALS-associated mutant HNRNPA2B1 in the nervous system. Neuron. 2016;92:780&#x2013;795. doi: 10.1016/j.neuron.2016.09.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.050</ArticleId><ArticleId IdType="pmc">PMC5123850</ArticleId><ArticleId IdType="pubmed">27773581</ArticleId></ArticleIdList></Reference><Reference><Citation>Matunis MJ, Michael WM, Dreyfuss G. Characterization and primary structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein. Mol Cell Biol. 1992;12:164&#x2013;171. doi: 10.1128/mcb.12.1.164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.12.1.164</ArticleId><ArticleId IdType="pmc">PMC364080</ArticleId><ArticleId IdType="pubmed">1729596</ArticleId></ArticleIdList></Reference><Reference><Citation>McClory SP, Lynch KW, Ling JP. HnRNP L represses cryptic exons. RNA. 2018;24:761&#x2013;768. doi: 10.1261/rna.065508.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.065508.117</ArticleId><ArticleId IdType="pmc">PMC5959245</ArticleId><ArticleId IdType="pubmed">29581412</ArticleId></ArticleIdList></Reference><Reference><Citation>McCloskey A, Taniguchi I, Shinmyozu K, Ohno M. hnRNP C tetramer measures RNA length to classify RNA polymerase II transcripts for export. Science. 2012;335:1643&#x2013;1646. doi: 10.1126/science.1218469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218469</ArticleId><ArticleId IdType="pubmed">22461616</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, L&#xf3;pez-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci. 2019;22:180&#x2013;190. doi: 10.1038/s41593-018-0293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill BM, Barnett SF, LeStourgeon WM, Williams KR. Primary structure differences between proteins C1 and C2 of HeLa 40S nuclear ribonucleoprotein particles. Nucleic Acids Res. 1989;17:8441&#x2013;8449. doi: 10.1093/nar/17.21.8441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/17.21.8441</ArticleId><ArticleId IdType="pmc">PMC335017</ArticleId><ArticleId IdType="pubmed">2587210</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael WM, Eder PS, Dreyfuss G. The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein. EMBO J. 1997;16:3587&#x2013;3598. doi: 10.1093/emboj/16.12.3587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/16.12.3587</ArticleId><ArticleId IdType="pmc">PMC1169983</ArticleId><ArticleId IdType="pubmed">9218800</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikolaskova B, Jurcik M, Cipakova I, Kretova M, Chovanec M, Cipak L. Maintenance of genome stability: the unifying role of interconnections between the DNA damage response and RNA-processing pathways. Curr Genet. 2018;64:971&#x2013;983. doi: 10.1007/s00294-018-0819-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00294-018-0819-7</ArticleId><ArticleId IdType="pubmed">29497809</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, McGoldrick P, Vance C, Hortobagyi T, Sreedharan J, Rogelj B, et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J, Hegde ML. A commentary on TDP-43 and DNA damage response in amyotrophic lateral sclerosis. J Exp Neurosci. 2019;13:1179069519880166. doi: 10.1177/1179069519880166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179069519880166</ArticleId><ArticleId IdType="pmc">PMC6791036</ArticleId><ArticleId IdType="pubmed">31656396</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Lammich S, Mackenzie IRA, Forn&#xe9; I, Zilow S, Kretzschmar H, et al. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol. 2013;125:413&#x2013;423. doi: 10.1007/s00401-013-1088-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1088-7</ArticleId><ArticleId IdType="pubmed">23381195</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Nihei Y, Arzberger T, Zhou Q, Mackenzie IR, Hermann A, et al. Reduced hnRNPA3 increases C9orf72 repeat RNA levels and dipeptide-repeat protein deposition. EMBO Rep. 2016;17:1314&#x2013;1325. doi: 10.15252/embr.201541724.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541724</ArticleId><ArticleId IdType="pmc">PMC5007570</ArticleId><ArticleId IdType="pubmed">27461252</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D, Grubman A, Acevedo K, Yang S, Ke YD, Moujalled DM, et al. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway. Hum Mol Genet. 2017;26:1732&#x2013;1746. doi: 10.1093/hmg/ddx093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx093</ArticleId><ArticleId IdType="pubmed">28334913</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D, James JL, Yang S, Zhang K, Duncan C, Moujalled DM, et al. Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43. Hum Mol Genet. 2015;24:1655&#x2013;1669. doi: 10.1093/hmg/ddu578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu578</ArticleId><ArticleId IdType="pubmed">25410660</ArticleId></ArticleIdList></Reference><Reference><Citation>Moumen A, Masterson P, O&#x2019;Connor MJ, Jackson SP. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell. 2005;123:1065&#x2013;1078. doi: 10.1016/j.cell.2005.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.09.032</ArticleId><ArticleId IdType="pubmed">16360036</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourelatos Z, Abel L, Yong J, Kataoka N, Dreyfuss G. SMN interacts with a novel family of hnRNP and spliceosomal proteins. EMBO J. 2001;20:5443&#x2013;5452. doi: 10.1093/emboj/20.19.5443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.19.5443</ArticleId><ArticleId IdType="pmc">PMC125643</ArticleId><ArticleId IdType="pubmed">11574476</ArticleId></ArticleIdList></Reference><Reference><Citation>Moursy A, Allain FH-T, Cl&#xe9;ry A. Characterization of the RNA recognition mode of hnRNP G extends its role in SMN2 splicing regulation. Nucleic Acids Res. 2014;42:6659&#x2013;6672. doi: 10.1093/nar/gku244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku244</ArticleId><ArticleId IdType="pmc">PMC4041419</ArticleId><ArticleId IdType="pubmed">24692659</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz DG, Neumann M, Kusaka H, Yokota O, Ishihara K, Terada S, Kuroda S, Mackenzie IR. FUS pathology in basophilic inclusion body disease. Acta Neuropathol. 2009;118:617&#x2013;627. doi: 10.1007/s00401-009-0598-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0598-9</ArticleId><ArticleId IdType="pubmed">19830439</ArticleId></ArticleIdList></Reference><Reference><Citation>Myer VE, Steitz JA. Isolation and characterization of a novel, low abundance hnRNP protein: A0. RNA. 1995;1:171&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369071</ArticleId><ArticleId IdType="pubmed">7585247</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakielny S, Dreyfuss G. The hnRNP C proteins contain a nuclear retention sequence that can override nuclear export signals. J Cell Biol. 1996;134:1365&#x2013;1373. doi: 10.1083/jcb.134.6.1365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.134.6.1365</ArticleId><ArticleId IdType="pmc">PMC2121000</ArticleId><ArticleId IdType="pubmed">8830767</ArticleId></ArticleIdList></Reference><Reference><Citation>Naro C, Bielli P, Pagliarini V, Sette C. The interplay between DNA damage response and RNA processing: the unexpected role of splicing factors as gatekeepers of genome stability. Front Genet. 2015;6:142. doi: 10.3389/fgene.2015.00142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2015.00142</ArticleId><ArticleId IdType="pmc">PMC4397863</ArticleId><ArticleId IdType="pubmed">25926848</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazim M, Masuda A, Rahman MA, Nasrin F, Takeda J-I, Ohe K, et al. Competitive regulation of alternative splicing and alternative polyadenylation by hnRNP H and CstF64 determines acetylcholinesterase isoforms. Nucleic Acids Res. 2017;45:1455&#x2013;1468. doi: 10.1093/nar/gkw823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw823</ArticleId><ArticleId IdType="pmc">PMC5388418</ArticleId><ArticleId IdType="pubmed">28180311</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Bentmann E, Dormann D, Jawaid A, DeJesus-Hernandez M, Ansorge O, et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain. 2011;134:2595&#x2013;2609. doi: 10.1093/brain/awr201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr201</ArticleId><ArticleId IdType="pmc">PMC3170539</ArticleId><ArticleId IdType="pubmed">21856723</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Roeber S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IRA. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol. 2009;118:605&#x2013;616. doi: 10.1007/s00401-009-0581-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0581-5</ArticleId><ArticleId IdType="pmc">PMC2864784</ArticleId><ArticleId IdType="pubmed">19669651</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihei Y, Mori K, Werner G, Arzberger T, Zhou Q, Khosravi B, et al. Poly-glycine-alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3. Acta Neuropathol. 2020;139:99&#x2013;118. doi: 10.1007/s00401-019-02082-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02082-0</ArticleId><ArticleId IdType="pmc">PMC6942035</ArticleId><ArticleId IdType="pubmed">31642962</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M, Talbot K, Ansorge O. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models. Acta Neuropathol Commun. 2016;4:99. doi: 10.1186/s40478-016-0358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0358-8</ArticleId><ArticleId IdType="pmc">PMC5011941</ArticleId><ArticleId IdType="pubmed">27600654</ArticleId></ArticleIdList></Reference><Reference><Citation>Okunola HL, Krainer AR. Cooperative-binding and splicing-repressive properties of hnRNP A1. Mol Cell Biol. 2009;29:5620&#x2013;5631. doi: 10.1128/MCB.01678-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01678-08</ArticleId><ArticleId IdType="pmc">PMC2756886</ArticleId><ArticleId IdType="pubmed">19667073</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostareck-Lederer A, Ostareck DH, Hentze MW. Cytoplasmic regulatory functions of the KH-domain proteins hnRNPs K and E1/E2. Trends Biochem Sci. 1998;23:409&#x2013;411. doi: 10.1016/s0968-0004(98)01301-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0968-0004(98)01301-2</ArticleId><ArticleId IdType="pubmed">9852755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdilek BA, Thompson VF, Ahmed NS, White CI, Batey RT, Schwartz JC. Intrinsically disordered RGG/RG domains mediate degenerate specificity in RNA binding. Nucleic Acids Res. 2017;45:7984&#x2013;7996. doi: 10.1093/nar/gkx460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx460</ArticleId><ArticleId IdType="pmc">PMC5570134</ArticleId><ArticleId IdType="pubmed">28575444</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahlich S, Quero L, Roschitzki B, Leemann-Zakaryan RP, Gehring H. Analysis of Ewing sarcoma (EWS)-binding proteins: interaction with hnRNP M, U, and RNA-helicases p68/72 within protein-RNA complexes. J Proteome Res. 2009;8:4455&#x2013;4465. doi: 10.1021/pr900235t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr900235t</ArticleId><ArticleId IdType="pubmed">19673543</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradis C, Cloutier P, Shkreta L, Toutant J, Klarskov K, Chabot B. hnRNP I/PTB can antagonize the splicing repressor activity of SRp30c. RNA. 2007;13:1287&#x2013;1300. doi: 10.1261/rna.403607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.403607</ArticleId><ArticleId IdType="pmc">PMC1924885</ArticleId><ArticleId IdType="pubmed">17548433</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelisch F, Pozzi B, Risso G, Mu&#xf1;oz MJ, Srebrow A. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation. J Biol Chem. 2012;287:30789&#x2013;30799. doi: 10.1074/jbc.M112.390120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.390120</ArticleId><ArticleId IdType="pmc">PMC3436322</ArticleId><ArticleId IdType="pubmed">22825850</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, et al. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J. 1998;17:4442&#x2013;4455. doi: 10.1093/emboj/17.15.4442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/17.15.4442</ArticleId><ArticleId IdType="pmc">PMC1170776</ArticleId><ArticleId IdType="pubmed">9687511</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering BM, Mitchell SA, Evans JR, Willis AE. Polypyrimidine tract binding protein and poly r(C) binding protein 1 interact with the BAG-1 IRES and stimulate its activity in vitro and in vivo. Nucleic Acids Res. 2003;31:639&#x2013;646. doi: 10.1093/nar/gkg146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg146</ArticleId><ArticleId IdType="pmc">PMC140511</ArticleId><ArticleId IdType="pubmed">12527772</ArticleId></ArticleIdList></Reference><Reference><Citation>Pi&#xf1;ol-Roma S, Choi YD, Matunis MJ, Dreyfuss G. Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes Dev. 1988;2:215&#x2013;227. doi: 10.1101/gad.2.2.215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.2.2.215</ArticleId><ArticleId IdType="pubmed">3129338</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad DD, Ouchida M, Lee L, Rao VN, Reddy ES. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene. 1994;9:3717&#x2013;3729.</Citation><ArticleIdList><ArticleId IdType="pubmed">7970732</ArticleId></ArticleIdList></Reference><Reference><Citation>Purice MD, Taylor JP. Linking hnRNP function to ALS and FTD pathology. Front Neurosci. 2018;12:326. doi: 10.3389/fnins.2018.00326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00326</ArticleId><ArticleId IdType="pmc">PMC5962818</ArticleId><ArticleId IdType="pubmed">29867335</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian H, Kang X, Hu J, Zhang D, Liang Z, Meng F, et al. Reversing a model of Parkinson&#x2019;s disease with in situ converted nigral neurons. Nature. 2020;582:550&#x2013;556. doi: 10.1038/s41586-020-2388-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2388-4</ArticleId><ArticleId IdType="pmc">PMC7521455</ArticleId><ArticleId IdType="pubmed">32581380</ArticleId></ArticleIdList></Reference><Reference><Citation>Radford H, Moreno JA, Verity N, Halliday M, Mallucci GR. PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia. Acta Neuropathol. 2015;130:633&#x2013;642. doi: 10.1007/s00401-015-1487-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1487-z</ArticleId><ArticleId IdType="pmc">PMC4612323</ArticleId><ArticleId IdType="pubmed">26450683</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J Neurochem. 2016;138(Suppl 1):95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Reches A, Nachmani D, Berhani O, Duev-Cohen A, Shreibman D, Ophir Y, et al. HNRNPR regulates the expression of classical and nonclassical MHC class I proteins. J Immunol. 2016;196:4967&#x2013;4976. doi: 10.4049/jimmunol.1501550.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501550</ArticleId><ArticleId IdType="pubmed">27194785</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-S&#xe1;nchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer JD, Warren JD. Phenotypic signatures of genetic frontotemporal dementia. Curr Opin Neurol. 2011;24:542&#x2013;549. doi: 10.1097/WCO.0b013e32834cd442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e32834cd442</ArticleId><ArticleId IdType="pubmed">21986680</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshon MJ, Ruley HE. Hypomorphic mutation in hnRNP U results in post-implantation lethality. Transgenic Res. 2005;14:179&#x2013;192. doi: 10.1007/s11248-004-8147-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11248-004-8147-8</ArticleId><ArticleId IdType="pubmed">16022389</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossbach O, Hung L-H, Khrameeva E, Schreiner S, K&#xf6;nig J, Curk T, et al. Crosslinking-immunoprecipitation (iCLIP) analysis reveals global regulatory roles of hnRNP L. RNA Biol. 2014;11:146&#x2013;155. doi: 10.4161/rna.27991.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/rna.27991</ArticleId><ArticleId IdType="pmc">PMC3973733</ArticleId><ArticleId IdType="pubmed">24526010</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossbach O, Hung L-H, Schreiner S, Grishina I, Heiner M, Hui J, et al. Auto- and cross-regulation of the hnRNP L proteins by alternative splicing. Mol Cell Biol. 2009;29:1442&#x2013;1451. doi: 10.1128/MCB.01689-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01689-08</ArticleId><ArticleId IdType="pmc">PMC2648227</ArticleId><ArticleId IdType="pubmed">19124611</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S, Serrano A, Gerbino V, Giorgi A, Di Francesco L, Nencini M, et al. Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS. J Cell Sci. 2015;128:1787&#x2013;1799. doi: 10.1242/jcs.165332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.165332</ArticleId><ArticleId IdType="pubmed">25788698</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossoll W, Jablonka S, Andreassi C, Kr&#xf6;ning A-K, Karle K, Monani UR, et al. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol. 2003;163:801&#x2013;812. doi: 10.1083/jcb.200304128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200304128</ArticleId><ArticleId IdType="pmc">PMC2173668</ArticleId><ArticleId IdType="pubmed">14623865</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M, Moncada A, Conte A, Lattante S, Marangi G, Luigetti M, et al. Mutations in the 3&#x2032; untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. Hum Mol Genet. 2013;22:4748&#x2013;4755. doi: 10.1093/hmg/ddt328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt328</ArticleId><ArticleId IdType="pubmed">23847048</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaber J, Talbot K. What is the role of TDP-43 in C9orf72-related amyotrophic lateral sclerosis and frontemporal dementia? Brain. 2016;139:3057&#x2013;3059. doi: 10.1093/brain/aww264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww264</ArticleId><ArticleId IdType="pubmed">27913405</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton CF, Good SK, Atkin S, Dewey CM, Mayer P, Herz J, et al. TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem. 2010;285:6826&#x2013;6834. doi: 10.1074/jbc.M109.061846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.061846</ArticleId><ArticleId IdType="pmc">PMC2825476</ArticleId><ArticleId IdType="pubmed">20040602</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivakumar P, De Giorgio F, Ule AM, Neeves J, Nair RR, Bentham M, et al. TDP-43 mutations increase HNRNP A1&#x2013;7B through gain of splicing function. Brain. 2018;141:e83. doi: 10.1093/brain/awy260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy260</ArticleId><ArticleId IdType="pubmed">30364928</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrisovska L, Bourgeois CF, Stefl R, Grellscheid S-N, Kister L, Wenter P, et al. The testis-specific human protein RBMY recognizes RNA through a novel mode of interaction. EMBO Rep. 2007;8:372&#x2013;379. doi: 10.1038/sj.embor.7400910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7400910</ArticleId><ArticleId IdType="pmc">PMC1852761</ArticleId><ArticleId IdType="pubmed">17318228</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;derberg M, Raffalli-Mathieu F, Lang MA. Inflammation modulates the interaction of heterogeneous nuclear ribonucleoprotein (hnRNP) I/polypyrimidine tract binding protein and hnRNP L with the 3&#x2019;untranslated region of the murine inducible nitric-oxide synthase mRNA. Mol Pharmacol. 2002;62:423&#x2013;431. doi: 10.1124/mol.62.2.423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.62.2.423</ArticleId><ArticleId IdType="pubmed">12130696</ArticleId></ArticleIdList></Reference><Reference><Citation>Soulard M, Della Valle V, Siomi MC, Pi&#xf1;ol-Roma S, Codogno P, Bauvy C, et al. hnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res. 1993;21:4210&#x2013;4217. doi: 10.1093/nar/21.18.4210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/21.18.4210</ArticleId><ArticleId IdType="pmc">PMC310052</ArticleId><ArticleId IdType="pubmed">7692398</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Shibagaki Y, Hattori S, Matsuoka M. Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs. Hum Mol Genet. 2015;24:1513&#x2013;1527. doi: 10.1093/hmg/ddu563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu563</ArticleId><ArticleId IdType="pubmed">25378556</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Shibagaki Y, Hattori S, Matsuoka M. C9-ALS/FTD-linked proline-arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation. Cell Death Dis. 2019;10:746. doi: 10.1038/s41419-019-1983-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1983-5</ArticleId><ArticleId IdType="pmc">PMC6776546</ArticleId><ArticleId IdType="pubmed">31582731</ArticleId></ArticleIdList></Reference><Reference><Citation>Svetoni F, Frisone P, Paronetto MP. Role of FET proteins in neurodegenerative disorders. RNA Biol. 2016;13:1089&#x2013;1102. doi: 10.1080/15476286.2016.1211225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2016.1211225</ArticleId><ArticleId IdType="pmc">PMC5100351</ArticleId><ArticleId IdType="pubmed">27415968</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahama K, Takada A, Tada S, Shimizu M, Sayama K, Kurokawa R, et al. Regulation of telomere length by G-quadruplex telomere DNA- and TERRA-binding protein TLS/FUS. Chem Biol. 2013;20:341&#x2013;350. doi: 10.1016/j.chembiol.2013.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2013.02.013</ArticleId><ArticleId IdType="pubmed">23521792</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q, Yalamanchili HK, Park J, De Maio A, Lu H-C, Wan Y-W, et al. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models. Hum Mol Genet. 2016;25:5083&#x2013;5093. doi: 10.1093/hmg/ddw337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw337</ArticleId><ArticleId IdType="pmc">PMC5968355</ArticleId><ArticleId IdType="pubmed">28007900</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Toro A, Sahana TG, Gao J, Chalk J, Oskarsson BE, et al. Divergence, convergence, and therapeutic implications: a cell biology perspective of C9ORF72-ALS/FTD. Mol Neurodegener. 2020;15:34. doi: 10.1186/s13024-020-00383-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00383-7</ArticleId><ArticleId IdType="pmc">PMC7282082</ArticleId><ArticleId IdType="pubmed">32513219</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateishi T, Hokonohara T, Yamasaki R, Miura S, Kikuchi H, Iwaki A, et al. Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation. Acta Neuropathol. 2010;119:355&#x2013;364. doi: 10.1007/s00401-009-0621-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0621-1</ArticleId><ArticleId IdType="pubmed">19967541</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavanez JP, Madl T, Kooshapur H, Sattler M, Valc&#xe1;rcel J. hnRNP A1 proofreads 3&#x2032; splice site recognition by U2AF. Mol Cell. 2012;45:314&#x2013;329. doi: 10.1016/j.molcel.2011.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.11.033</ArticleId><ArticleId IdType="pubmed">22325350</ArticleId></ArticleIdList></Reference><Reference><Citation>Titlow J, Robertson F, J&#xe4;rvelin A, Ish-Horowicz D, Smith C, Gratton E, et al. Syncrip/hnRNP Q is required for activity-induced Msp300/Nesprin-1 expression and new synapse formation. J Cell Biol. 2020 doi: 10.1083/jcb.201903135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201903135</ArticleId><ArticleId IdType="pmc">PMC7055005</ArticleId><ArticleId IdType="pubmed">32040548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Wang Z, Hortob&#xe1;gyi T, Witten JT, Zarnack K, Kayikci M, et al. Analysis of alternative splicing associated with aging and neurodegeneration in the human brain. Genome Res. 2011;21:1572&#x2013;1582. doi: 10.1101/gr.122226.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.122226.111</ArticleId><ArticleId IdType="pmc">PMC3202275</ArticleId><ArticleId IdType="pubmed">21846794</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres P, Andr&#xe9;s-Benito P, Fern&#xe0;ndez-Bernal A, Ricart M, Ayala V, Pamplona R, et al. Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer&#x2019;s disease with and without associated TDP-43 proteinopathy. Brain. 2020;143:e20. doi: 10.1093/brain/awaa013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa013</ArticleId><ArticleId IdType="pubmed">32016361</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabzuni D, Wray S, Vandrovcova J, Ramasamy A, Walker R, Smith C, et al. MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet. 2012;21:4094&#x2013;4103. doi: 10.1093/hmg/dds238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds238</ArticleId><ArticleId IdType="pmc">PMC3428157</ArticleId><ArticleId IdType="pubmed">22723018</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortob&#xe1;gyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Venables JP, Koh C-S, Froehlich U, Lapointe E, Couture S, Inkel L, et al. Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol Cell Biol. 2008;28:6033&#x2013;6043. doi: 10.1128/MCB.00726-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00726-08</ArticleId><ArticleId IdType="pmc">PMC2547008</ArticleId><ArticleId IdType="pubmed">18644864</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorechovsky I. Transposable elements in disease-associated cryptic exons. Hum Genet. 2010;127:135&#x2013;154. doi: 10.1007/s00439-009-0752-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-009-0752-4</ArticleId><ArticleId IdType="pubmed">19823873</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuong JK, Lin C-H, Zhang M, Chen L, Black DL, Zheng S. PTBP1 and PTBP2 serve both specific and redundant functions in neuronal pre-mRNA splicing. Cell Rep. 2016;17:2766&#x2013;2775. doi: 10.1016/j.celrep.2016.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.11.034</ArticleId><ArticleId IdType="pmc">PMC5179036</ArticleId><ArticleId IdType="pubmed">27926877</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner BJ, DeMaria CT, Sun Y, Wilson GM, Brewer G. Structure and genomic organization of the human AUF1 gene: alternative pre-mRNA splicing generates four protein isoforms. Genomics. 1998;48:195&#x2013;202. doi: 10.1006/geno.1997.5142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.1997.5142</ArticleId><ArticleId IdType="pubmed">9521873</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner EJ, Garcia-Blanco MA. Polypyrimidine tract binding protein antagonizes exon definition. Mol Cell Biol. 2001;21:3281&#x2013;3288. doi: 10.1128/MCB.21.10.3281-3288.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.21.10.3281-3288.2001</ArticleId><ArticleId IdType="pmc">PMC100250</ArticleId><ArticleId IdType="pubmed">11313454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Hegde ML. New mechanisms of DNA repair defects in fused in sarcoma-associated neurodegeneration: stage set for DNA repair-based therapeutics? J Exp Neurosci. 2019;13:1179069519856358. doi: 10.1177/1179069519856358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179069519856358</ArticleId><ArticleId IdType="pmc">PMC6558540</ArticleId><ArticleId IdType="pubmed">31217692</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Gao Q-S, Wang Y, Lafyatis R, Stamm S, Andreadis A. Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors. J Neurochem. 2004;88:1078&#x2013;1090. doi: 10.1046/j.1471-4159.2003.02232.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.02232.x</ArticleId><ArticleId IdType="pubmed">15009664</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wang J, Gao L, Stamm S, Andreadis A. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5&#x2019; splice site of tau exon 10, whose misregulation causes frontotemporal dementia. Gene. 2011;485:130&#x2013;138. doi: 10.1016/j.gene.2011.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2011.06.020</ArticleId><ArticleId IdType="pmc">PMC3163755</ArticleId><ArticleId IdType="pubmed">21723381</ArticleId></ArticleIdList></Reference><Reference><Citation>West KO, Scott HM, Torres-Odio S, West AP, Patrick KL, Watson RO. The splicing factor hnRNP M is a critical regulator of innate immune gene expression in macrophages. Cell Rep. 2019;29:1594&#x2013;1609.e5. doi: 10.1016/j.celrep.2019.09.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.078</ArticleId><ArticleId IdType="pmc">PMC6981299</ArticleId><ArticleId IdType="pubmed">31693898</ArticleId></ArticleIdList></Reference><Reference><Citation>White A, Moujalled D, James J, Grubman A, Kanninen K, Crouch P. Phosphorylation of hnRNP K controls cytosolic accumulation of TDP-43. Mol Neurodegener. 2013;8:P46. doi: 10.1186/1750-1326-8-S1-P46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-S1-P46</ArticleId></ArticleIdList></Reference><Reference><Citation>White MA, Kim E, Duffy A, Adalbert R, Phillips BU, Peters OM, et al. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat Neurosci. 2018;21:552&#x2013;563. doi: 10.1038/s41593-018-0113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0113-5</ArticleId><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson MF. Genetic paradox explained by nonsense. Nature. 2019;568:179&#x2013;180. doi: 10.1038/d41586-019-00823-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-019-00823-5</ArticleId><ArticleId IdType="pubmed">30962551</ArticleId></ArticleIdList></Reference><Reference><Citation>Wollerton MC, Gooding C, Wagner EJ, Garcia-Blanco MA, Smith CWJ. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol Cell. 2004;13:91&#x2013;100. doi: 10.1016/s1097-2765(03)00502-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1097-2765(03)00502-1</ArticleId><ArticleId IdType="pubmed">14731397</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B, Ivanov P. Stress granules and neurodegeneration. Nat Rev Neurosci. 2019;20:649&#x2013;666. doi: 10.1038/s41583-019-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0222-5</ArticleId><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao R, Tang P, Yang B, Huang J, Zhou Y, Shao C, et al. Nuclear matrix factor hnRNP U/SAF-A exerts a global control of alternative splicing by regulating U2 snRNP maturation. Mol Cell. 2012;45:656&#x2013;668. doi: 10.1016/j.molcel.2012.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2012.01.009</ArticleId><ArticleId IdType="pmc">PMC3299905</ArticleId><ArticleId IdType="pubmed">22325991</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X, Wang Z, Jang M, Nutiu R, Wang ET, Burge CB. Splice site strength-dependent activity and genetic buffering by poly-G runs. Nat Struct Mol Biol. 2009;16:1094&#x2013;1100. doi: 10.1038/nsmb.1661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1661</ArticleId><ArticleId IdType="pmc">PMC2766517</ArticleId><ArticleId IdType="pubmed">19749754</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu N, Chen CY, Shyu AB. Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol Cell Biol. 2001;21:6960&#x2013;6971. doi: 10.1128/MCB.21.20.6960-6971.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.21.20.6960-6971.2001</ArticleId><ArticleId IdType="pmc">PMC99872</ArticleId><ArticleId IdType="pubmed">11564879</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y, Qian H, Hu J, Zhou B, Zhou Y, Hu X, et al. Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells. Nat Neurosci. 2016;19:807&#x2013;815. doi: 10.1038/nn.4297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4297</ArticleId><ArticleId IdType="pmc">PMC4882254</ArticleId><ArticleId IdType="pubmed">27110916</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarnack K, K&#xf6;nig J, Tajnik M, Martincorena I, Eustermann S, St&#xe9;vant I, et al. Direct competition between hnRNP C and U2AF65 protects the transcriptome from the exonization of Alu elements. Cell. 2013;152:453&#x2013;466. doi: 10.1016/j.cell.2012.12.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.12.023</ArticleId><ArticleId IdType="pmc">PMC3629564</ArticleId><ArticleId IdType="pubmed">23374342</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q-S, Manche L, Xu R-M, Krainer AR. hnRNP A1 associates with telomere ends and stimulates telomerase activity. RNA. 2006;12:1116&#x2013;1128. doi: 10.1261/rna.58806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.58806</ArticleId><ArticleId IdType="pmc">PMC1464852</ArticleId><ArticleId IdType="pubmed">16603717</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Su J, Hu X, Zhou C, Li H, Chen Z, et al. Glia-to-neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice. Cell. 2020;181:590&#x2013;603.e16. doi: 10.1016/j.cell.2020.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.024</ArticleId><ArticleId IdType="pubmed">32272060</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Liu S, Liu G, Ozt&#xfc;rk A, Hicks GG. ALS-associated FUS mutations result in compromised FUS alternative splicing and autoregulation. PLoS Genet. 2013;9:e1003895. doi: 10.1371/journal.pgen.1003895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003895</ArticleId><ArticleId IdType="pmc">PMC3814325</ArticleId><ArticleId IdType="pubmed">24204307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A, et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat Neurosci. 2020;23:615&#x2013;624. doi: 10.1038/s41593-020-0619-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinszner H, Sok J, Immanuel D, Yin Y, Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci. 1997;110(Pt 15):1741&#x2013;1750.</Citation><ArticleIdList><ArticleId IdType="pubmed">9264461</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>